ASGE Postgraduate Course at ACG 2022: Expanding the Scope of Fundamental and Advanced Endoscopy | October 2022-State of the Art Lecture: Risk Stratification and Treatment of UGI Bleeding

State of the Art Lecture: Risk Stratification and Treatment of UGI Bleeding

Video Transcription

Video Summary

In the video, Dr. Alan Barkin, a professor at McGill University, discusses the state-of-the-art in risk stratification and treatment of upper gastrointestinal (GI) bleeding. He bases his recommendations on various guidelines, including the 2019 Multi-Society, Multi-Country Guidelines, the European Society of Gastrointestinal Endoscopy guidelines, and the American College of Gastroenterology (ACG) guidelines. He highlights that the mortality rate of non-variceal upper GI bleeding has decreased over the past decade and is now around 2%. Mortality is primarily related to comorbid illnesses such as malignancy and chronic kidney disease. Dr. Barkin discusses the management of upper GI bleeding, emphasizing the importance of endoscopic hemostasis. He also addresses topics such as risk assessment using the Glasgow Blatchford score, admission criteria, the use of proton pump inhibitors (PPIs), timing of endoscopy, choice of endoscopic therapy, and peri-endoscopic management of patients on antithrombotic medications. He provides recommendations for each of these areas based on the available evidence. The video concludes by summarizing the key recommendations discussed throughout the presentation.

Asset Subtitle

Alan N. Barkum, MD, CM, MSc, FASGE, FACG

Keywords

upper gastrointestinal bleeding

endoscopic hemostasis

Glasgow Blatchford score

proton pump inhibitors

endoscopic therapy

antithrombotic medications